Skip to main content
Premium Trial:

Request an Annual Quote

Pumping Iron

Premium

A new report from British cancer charity Macmillan Cancer Support is turning the conventional wisdom of exercise for cancer patients on its head, says The New York Times' Anahad O'Connor. Whereas many people who have cancer may be inclined to rest after receiving treatment, the new report says that patients actually should increase their level of physical activity. The report is based on the findings of 60 studies on the effects of exercise on cancer. "Saying some patients should view light exercise almost as a form of treatment itself, the report noted that two and a half hours of exercise a week could lower a breast cancer patient's risk of dying or cancer recurrence by 40 percent, and could reduce a prostate cancer patient's risk of dying from the disease by about 30 percent," O'Connor says. For some patients, light or moderate exercise even helped reduce some of the side effects of cancer treatment. "For patients looking for help with starting a new regimen, the American College of Sports Medicine and the American Cancer Society introduced a program that educates and certifies trainers to work specifically with cancer patients, so they understand their goals and limitations," O'Connor adds.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.